For Immediate Release, 6/20/2007
Contact: Jian Wang, Ph.D.
President & CEO
BioFortis, Inc.
443-276-2464 X 2470
jwang@biofortis.com


BioFortis Awarded Incubator of the Year
Company Recognized by Maryland Technology Community


June 20, 2007 —BioFortis has won Maryland’s Incubator of the Year Award, the company announced today. The award, sponsored by Saul Ewing LLP, RSM McGladrey, Inc., Maryland Technology Development Corporation (TEDCO) and Maryland Department of Business & Economic Development (DBED), recognizes significant achievement in technology development, innovation and growth of companies arising from the state’s business incubators. BioFortis was recognized as a successful technology transfer from the Johns Hopkins Medical Institute where the technology behind BioFortis’ flagship product, Labmatrix™, was initially developed. The company is a successful graduate of the Emerging Technology Center in Baltimore.

“Labmatrix supports the research that is making personalized medicine a reality,” commented Dr. Ethel Rubin, BioFortis’ Chief Scientific Officer, in accepting the award at the ceremony held in Baltimore’s Center Club on June 20. Rubin further acknowledged BioFortis’ customers, all prestigious research institutions leading cutting-edge studies in multiple therapeutic areas, for their rapid and enthusiastic adoption of the technology. “By seamlessly integrating diverse and disparate datasets, Labmatrix speeds the discovery process and provides a flexible but powerful querying framework that far surpasses the capability of traditional scientific data management tools.” Rubin credits the company’s highly-skilled, multi-disciplinary product development and customer support staff for the success of Labmatrix, which had earlier been a finalist in the Greater Baltimore Committee’s Product of the Year award. The company has benefited from TEDCO and DBED programs and awards, accelerating product development.

About BioFortis
BioFortis is a privately-held company focused on providing biomedical research software and services to the life sciences sector, including academic medical centers, government labs, non-profit institutes, research consortia and the biopharmaceutical industry. BioFortis’ flagship product Labmatrix™, a web-based application enabling management and integration of clinical, genetic and molecular analytical data, provides tools for scientists to manage translational medicine study data and is a major component of research information technology infrastructure. Labmatrix enables transparent data management, integration, collaboration and compliance to privacy regulations. Labmatrix encompasses data management and cross-cutting query capabilities across patient clinical, genetic, sample and molecular analytical data. Applications include clinical research data management, biomarker discovery, biospecimen tracking and analysis.

# # #